The Food and Drug Administration wants to ramp up the way it regulates smartphone apps linked to prescription drugs — like medication reminders or symptom trackers.
In a new proposal released Monday, the agency said it may treat some apps like drug advertisements — which would allow companies to distribute apps without going through a review process with every update. Right now, the apps aren’t covered by existing regulations.